PCN45 COST EFFECTIVENESS OF ADDING IMATINIB TO CHEMOTHERAPY IN ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL):AN EXPLORATORY ANALYSIS FOR THE UK

Lymphoblastic Leukemia ◽

Philadelphia Chromosome ◽

Exploratory Analysis ◽

Adult Patients ◽

The Uk ◽

PIH8 Cost-Effectiveness Analysis Of Dasatinib Versus Imatinib In Treating Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients In China

Value in Health ◽

10.1016/j.jval.2021.04.526 ◽

2021 ◽

Vol 24 ◽

pp. S100

Author(s):

W. Cao ◽

Y. Yu ◽

L. Shi ◽

Y. Qiu ◽

H. Zhang ◽

...

Keyword(s):

Cost Effectiveness ◽

Lymphoblastic Leukemia ◽

Philadelphia Chromosome ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Frontiers of Medicine ◽

10.1007/s11684-017-0506-y ◽

2017 ◽

Vol 11 (2) ◽

pp. 229-238 ◽

Cited By ~ 5

Author(s):

Yinjun Lou ◽

Yafang Ma ◽

Chenyin Li ◽

Sansan Suo ◽

Hongyan Tong ◽

...

Keyword(s):

Prognostic Factors ◽

Lymphoblastic Leukemia ◽

Philadelphia Chromosome ◽

Adult Patients ◽

Newly Diagnosed ◽

Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome–positive B‐precursor acute lymphoblastic leukemia

Cancer ◽

10.1002/cncr.32558 ◽

2019 ◽

Vol 126 (2) ◽

pp. 304-310 ◽

Cited By ~ 8

Author(s):

Alessandro Rambaldi ◽

Josep‐Maria Ribera ◽

Hagop M. Kantarjian ◽

Hervé Dombret ◽

Oliver G. Ottmann ◽

...

Keyword(s):

Lymphoblastic Leukemia ◽

Philadelphia Chromosome ◽

Standard Of Care ◽

Adult Patients ◽

Cost-Effectiveness of Ponatinib in The Treatment of Patients with Acute Lymphoblastic Leukemia with Philadelphia Chromosome Positive (PH+ ALL), Suitable for Allogeneic Stem Cell Transplant, in Greece

Value in Health ◽

10.1016/j.jval.2017.08.232 ◽

2017 ◽

Vol 20 (9) ◽

pp. A438-A439

Author(s):

K Vellopoulou ◽

G Kourlaba ◽

P Giannoulia ◽

P Panagiotidis ◽

N Maniadakis

Keyword(s):

Stem Cell ◽

Cost Effectiveness ◽

Stem Cell Transplant ◽

Lymphoblastic Leukemia ◽

Philadelphia Chromosome ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

PCN73 COST-EFFECTIVENESS OF BLINATUMOMAB VERSUS STANDARD OF CARE IN ADULT PATIENTS WITH PHILADELPHIA-CHROMOSOME-POSITIVE RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA FROM A CANADIAN HEALTHCARE SECTOR PERSPECTIVE

Value in Health ◽

10.1016/j.jval.2020.04.1575 ◽

2020 ◽

Vol 23 ◽

pp. S36

Author(s):

T.E. Delea ◽

K. Raman ◽

D. Boyko ◽

A. Moynahan ◽

F. Dirnberger ◽

...

Keyword(s):

Cost Effectiveness ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Philadelphia Chromosome ◽

Standard Of Care ◽

Adult Patients ◽

Healthcare Sector ◽

Cell Precursor ◽

Canadian Healthcare

A pathway-based gene signature correlates with therapeutic response in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

Modern Pathology ◽

10.1038/modpathol.2010.137 ◽

2010 ◽

Vol 23 (11) ◽

pp. 1524-1534 ◽

Cited By ~ 5

Author(s):

Zhuang Zuo ◽

Dan Jones ◽

Hui Yao ◽

Deborah A Thomas ◽

Susan O'Brien ◽

...

Keyword(s):

Therapeutic Response ◽

Lymphoblastic Leukemia ◽

Philadelphia Chromosome ◽

Gene Signature ◽

Adult Patients ◽

Prognostic significance of recurrent additional chromosomal abnormalities in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

Cancer Genetics ◽

10.1016/j.cancergen.2017.06.001 ◽

2017 ◽

Vol 216-217 ◽

pp. 29-36 ◽

Cited By ~ 7

Author(s):

Chang Ahn Seol ◽

Young-Uk Cho ◽

Seongsoo Jang ◽

Chan-Jeoung Park ◽

Jung-Hee Lee ◽

...

Keyword(s):

Chromosomal Abnormalities ◽

Lymphoblastic Leukemia ◽

Prognostic Significance ◽

Philadelphia Chromosome ◽

Adult Patients ◽

Additional Chromosomal Abnormalities ◽

Current treatment options for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

Leukemia & Lymphoma ◽

10.3109/10428190903452834 ◽

2009 ◽

Vol 51 (2) ◽

pp. 188-198 ◽

Cited By ~ 16

Author(s):

Wendy Stock

Keyword(s):

Lymphoblastic Leukemia ◽

Treatment Options ◽

Philadelphia Chromosome ◽

Current Treatment ◽

Adult Patients ◽

Treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

Current Oncology Reports ◽

10.1007/s11912-008-0059-y ◽

2008 ◽

Vol 10 (5) ◽

pp. 379-387 ◽

Cited By ~ 4

Author(s):

Ryuzo Ohno

Keyword(s):

Lymphoblastic Leukemia ◽

Philadelphia Chromosome ◽

Adult Patients ◽

Faculty Opinions recommendation of Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718266974.793496733 ◽

2014 ◽

Author(s):

Jan Starý ◽

Michaela Kotrová

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Minimal Residual Disease ◽

Kinase Inhibitors ◽

Residual Disease ◽

Lymphoblastic Leukemia ◽

Philadelphia Chromosome ◽

Minimal Residual ◽